Strand Therapeutics

Risk score

57
Large logo of Strand Therapeutics

Headquarters

Flag of United States of AmericaUnited States of America

Strand originated from collaborative efforts of biological engineers at MIT, who aimed to innovate smart therapies through the application of mRNA therapeutics. The team established a new platform by developing a unique mRNA 'programming language' to enhance the safety and efficacy of therapeutic protein expression within the patient's body.